Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Search Results for synaptic

Yale-Developed Test for Alzheimer’s Disease Directly Measures Synaptic Loss

Published recently in JAMA https://jamanetwork.com/journals/jamaneurology/fullarticle/2687472 Yale’s Ziba Kashef reported “researchers have tested a new method for directly measuring synaptic loss in […]

3 years ago
Share

BioHaven’s Troriluzole Fails Co-Primary Endpoints in Phase 2 Trial for Mild-to-Moderate Alzheimer’s Disease

BioHaven Pharmaceuticals announced the outcome from a focused analysis of the topline co-primary and key secondary data from its Phase […]

BioHaven’s Troriluzole Fails Co-Primary Endpoints in Phase 2 Trial for Mild-to-Moderate Alzheimer's Disease
1 month ago
Share

Eumentis Closes $3.9 Million Series A Round to Develop Neurodevelopmental and Neurodegenerative Treatments

Eumentis Therapeutics announced the closing of its $3.9 million Series A financing. Proceeds from the financing will be used to […]

Eumentis Closes $3.9 Million Series A Round to Develop Neurodevelopmental and Neurodegenerative Treatments
4 months ago
Share

EIP Pharma Reports Positive Phase 2 Data for Neflamapimod in Mild-to-Moderate Dementia with Lewy bodies

EIP Pharma announced positive results from the Phase 2 AscenD-LB study in patients with mild-to-moderate dementia with Lewy bodies (DLB). […]

EIP Pharma Reports Positive Phase 2 Data for Neflamapimod in Mild-to-Moderate Dementia with Lewy bodies
5 months ago
Share

NeuroTherapia Closes $8.8M Series A Financing to Progress Neuroinflammation Drug Candidates

Neurotherapia announced the closing of its Series A financing for $8.8M.  The Series A round was led by Brain Trust Accelerator […]

NeuroTherapia Closes $8.8M Series A Financing to Progress Neuroinflammation Drug Candidates
5 months ago
Share

Marinus Pharma’s Ganaxolone Reaches Phase 3 Endpoints in Rare Genetic Epilepsy Study

Marinus Pharmaceuticals announced positive results from the phase 3 MARIGOLD study, which evaluated oral ganaxolone in children and young adults […]

Marinus Pharma’s Ganaxolone Reaches Phase 3 Endpoints in Rare Genetic Epilepsy Study
6 months ago
Share

Biohaven Releases Positive Data from Phase 2/3 Study of Troriluzole in the Treatment of Obsessive-Compulsive Disorder (OCD)

Biohaven Pharmaceuticals announced positive topline results from its proof of concept study of troriluzole in the treatment of obsessive-compulsive disorder (OCD). […]

Biohaven Releases Positive Data from Phase 23 Study of Troriluzole in the Treatment of Obsessive-Compulsive Disorder (OCD)
8 months ago
Share

University of Illinois College of Medicine Rockford Investigators Secure $1.8m NIH Grant for Hereditary Spastic Paraplegia

University of Illinois College of Medicine Rockford researchers received a five-year grant totaling over $1.8 million from the National Institutes […]

University of Illinois College of Medicine Rockford Investigators Secure $1.8m NIH Grant for Hereditary Spastic Paraplegia
9 months ago
Share

Emory Researchers on the Move with Grant Awards & Publications

Emory University faculty and staff conduct research across every discipline. The Emory News Center recently published a summary of highlights […]

Emory Researchers on the Move with Grant Awards & Publications
1 year ago
Share

MRC London Institute of Medical Sciences with Breakthrough in Understanding Schizophrenia

Researchers from the Medical Research Council (MRC) London Institute of Medical Sciences report that based on a recent study powered by […]

MRC London Institute of Medical Sciences with Breakthrough in Understanding Schizophrenia
1 year ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.